265 related articles for article (PubMed ID: 6097775)
1. A monoclonal anti-tac antibody may interfere with receptor binding of interleukin 2.
Taniguchi N; Miyawaki T; Yachie A
Lymphokine Res; 1982; 1(4):107-12. PubMed ID: 6097775
[No Abstract] [Full Text] [Related]
2. Production of lymphokines by circulating human T lymphocytes that express or lack receptors for interleukin 2.
Palacios R
J Immunol; 1984 Apr; 132(4):1833-6. PubMed ID: 6321592
[TBL] [Abstract][Full Text] [Related]
3. Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes.
Tsoukas CD; Landgraf B; Bentin J; Valentine M; Lotz M; Vaughan JH; Carson DA
J Immunol; 1985 Sep; 135(3):1719-23. PubMed ID: 3926881
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of anti-CD3 (T3) antibody-induced activation of T cells by cyclosporine.
Bentin J; Carson DA; Vaughan JH; Tsoukas CD
Transplantation; 1986 Sep; 42(3):317-20. PubMed ID: 3092413
[No Abstract] [Full Text] [Related]
5. Activation of human thymocytes via the 50KD T11 sheep erythrocyte binding protein induces the expression of interleukin 2 receptors on both T3+ and T3- populations.
Fox DA; Hussey RE; Fitzgerald KA; Bensussan A; Daley JF; Schlossman SF; Reinherz EL
J Immunol; 1985 Jan; 134(1):330-5. PubMed ID: 2578045
[TBL] [Abstract][Full Text] [Related]
6. Effects of anti-Tac antibody on the response of large granular lymphocytes to interleukin-2.
Mukaida N; Kasahara T; Hosoi J; Shioiri-Nakano K; Kawai T
Immunology; 1986 Jan; 57(1):137-43. PubMed ID: 3002967
[TBL] [Abstract][Full Text] [Related]
7. Human T lymphocyte activation by monoclonal antibodies; OKT3, but not UCHT1, triggers mitogenesis via an interleukin 2-dependent mechanism.
Van Wauwe JP; Goossens JG; Beverley PC
J Immunol; 1984 Jul; 133(1):129-32. PubMed ID: 6327822
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation.
Depper JM; Leonard WJ; Robb RJ; Waldmann TA; Greene WC
J Immunol; 1983 Aug; 131(2):690-6. PubMed ID: 6408186
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 2 functions through novel interleukin 2 binding molecules in T cells.
Tanaka T; Saiki O; Doi S; Negoro S; Kishimoto S
J Immunol; 1988 Jan; 140(2):470-3. PubMed ID: 2826593
[TBL] [Abstract][Full Text] [Related]
10. In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin 2 and its receptor.
Modlin RL; Hofman FM; Horwitz DA; Husmann LA; Gillis S; Taylor CR; Rea TH
J Immunol; 1984 Jun; 132(6):3085-90. PubMed ID: 6327818
[TBL] [Abstract][Full Text] [Related]
11. Functional significance of Tac antigen expressed on activated human T lymphocytes: Tac antigen interacts with T cell growth factor in cellular proliferation.
Miyawaki T; Yachie A; Uwadana N; Ohzeki S; Nagaoki T; Taniguchi N
J Immunol; 1982 Dec; 129(6):2474-8. PubMed ID: 6982926
[TBL] [Abstract][Full Text] [Related]
12. Regulation of interleukin 2 receptor expression: effects of phorbol diester, phospholipase C, and reexposure to lectin or antigen.
Depper JM; Leonard WJ; Krönke M; Noguchi PD; Cunningham RE; Waldmann TA; Greene WC
J Immunol; 1984 Dec; 133(6):3054-61. PubMed ID: 6092466
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells.
Miyawaki T; Yachie A; Ohzeki S; Nagaoki T; Taniguchi N
J Immunol; 1983 Jun; 130(6):2737-42. PubMed ID: 6406595
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.
Waldmann TA; Leonard WJ; Depper JM; Krönke M; Goldman CK; Oh T; Greene WC
Princess Takamatsu Symp; 1984; 15():259-68. PubMed ID: 6100644
[TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant interleukin-2 on resting human T lymphocytes.
Hammer SM; Gillis JM
J Biol Response Mod; 1986 Feb; 5(1):36-44. PubMed ID: 3007679
[TBL] [Abstract][Full Text] [Related]
16. Activated human B cells display a functional IL 2 receptor.
Mittler R; Rao P; Olini G; Westberg E; Newman W; Hoffmann M; Goldstein G
J Immunol; 1985 Apr; 134(4):2393-9. PubMed ID: 2982945
[TBL] [Abstract][Full Text] [Related]
17. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate.
Lipkowitz S; Greene WC; Rubin AL; Novogrodsky A; Stenzel KH
J Immunol; 1984 Jan; 132(1):31-7. PubMed ID: 6418801
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of accessory cell requirement in inducing IL 2 responsiveness by human T4 lymphocytes that generate colonies under PHA stimulation.
Oudrhiri N; Farcet JP; Gourdin MF; Divine M; Bouguet J; Fradelizi D; Reyes F
J Immunol; 1985 Sep; 135(3):1813-8. PubMed ID: 3926884
[TBL] [Abstract][Full Text] [Related]
19. In vivo administration of purified human interleukin-2 to patients with cancer: development of interleukin-2 receptor positive cells and circulating soluble interleukin-2 receptors following interleukin-2 administration.
Lotze MT; Custer MC; Sharrow SO; Rubin LA; Nelson DL; Rosenberg SA
Cancer Res; 1987 Apr; 47(8):2188-95. PubMed ID: 3030546
[TBL] [Abstract][Full Text] [Related]
20. Normal and certain leukaemic B cells express IL-2 receptors without in vitro activation.
Armitage RJ; Cawley JC
Clin Exp Immunol; 1986 Feb; 63(2):298-302. PubMed ID: 3009062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
